The stock of Concordia International Corp (TSE:CXR) is a huge mover today! About 793,873 shares traded hands. Concordia International Corp (TSE:CXR) has declined 77.40% since February 5, 2016 and is downtrending. It has underperformed by 93.89% the S&P500.
The move comes after 5 months negative chart setup for the $427.77 million company. It was reported on Sep, 13 by Barchart.com. We have $7.48 PT which if reached, will make TSE:CXR worth $55.61 million less.
Out of 3 analysts covering Concordia Healthcare Corp (TSE:CXR), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. $105 is the highest target while $34 is the lowest. The $36.33 average target is 322.44% above today’s ($8.6) stock price. Concordia Healthcare Corp has been the topic of 12 analyst reports since September 28, 2015 according to StockzIntelligence Inc.
Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada pharmaceutical company. The company has a market cap of $427.77 million. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. It currently has negative earnings.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.